RIAS
SANA icon

Rachor Investment Advisory Services’s Sana Biotechnology SANA Stock Holding History

Rachor Investment Advisory Services’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-369
Closed -$1.06K – 380
2026
Q1 		$1.06K Hold
369
– – ﹤0.01% 316
2025
Q4 		$1.5K Buy
+369
New +$1.65K ﹤0.01% 271

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Rachor Investment Advisory Services's SANA Position: Q2 2026 in Review

Rachor Investment Advisory Services sold out of Sana Biotechnology (SANA) in Q2 2026, closing a stake of 369 shares — an estimated $1.06K sold.

Rachor Investment Advisory Services first reported a position in SANA in Q4 2025 and held it in 2 quarters. The position peaked at $1.5K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Rachor Investment Advisory Services reported no remaining Sana Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Rachor Investment Advisory Services sold 369 Sana Biotechnology shares in Q2 2026, an estimated $1.06K.
  • Rachor Investment Advisory Services first reported a position in Sana Biotechnology in Q4 2025 and held it in 2 quarters.
  • Rachor Investment Advisory Services's Sana Biotechnology position peaked at $1.5K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.